WHITE PAPER

Currently, oligodendrogliomas (OGs) are stratified into three molecular subgroups on the basis of IDH mutation and 1p/19q co-deletion. Amongst 1p/19q co-deleted OG tumors, there is molecular heterogeneity related to EGFR, PTEN, 10q deletion, and several other markers...

NetraAI represents a distinctive, Good Clinical Practice (GCP)-authenticated machine learning architecture that offers an accessible interface for researchers to engage with consolidated multimodal datasets. This empowers sponsors to uncover explainable patient...

Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers and can be divided into three histological subtypes with distinct presentation and prognoses: adenocarcinoma (ADC), squamous cell carcinoma (SCC), and large cell carcinoma (LCC).1 In addition to...

Alzheimer’s disease (AD) is a neurodegenerative disease that contributes to 60-70% of all dementia cases and is characterized by neuronal cell damage and cognitive decline.1 Currently, drugs for AD target symptom control and there is no effective curative therapy for...

Clinical scale patient reported outcomes are commonly used research tools that can be designed to provide quantitative or qualitative outputs. These assessments use objective scales and/or qualitative, open-ended responses that rely on self-reporting to collect...

Challenges with Pancreatic Cancer Pancreatic cancer is deemed the “silent killer” due to vague symptoms, late diagnosis, rapid progression, and poor response to therapy. As the 14th most common cancer but 7th leading cause of cancer-associated deaths, prolonging...